Nanosonics, AU000000NAN9

Nanosonics stock wins a Gold award for its CORIS system

Published on 10/08/2026 at 08:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nanosonics stock was last at AUD 2.870 on October 7, 2026, as CORIS won a Gold design award. Fiscal 2026 revenue rose 2.7 percent to AUD 203.9 million.

Nanosonics, AU000000NAN9, Illustration mit AI erstellt.
Nanosonics, AU000000NAN9, Illustration mit AI erstellt.

Nanosonics stock (ISIN AU000000NAN9) was last at AUD 2.870 on the ASX on October 7, 2026, after the CORIS System won Gold in the Medical and Scientific Product Design category at the 2026 Australian Good Design Awards. The award gives Nanosonics a fresh commercial marker for a product designed to automate flexible endoscope cleaning.

CORIS wins medical design recognition

Biotech Dispatch reported on October 8, 2026, that CORIS received the Gold honor for a system that automates cleaning before endoscope disinfection. The process replaces manual brushing and flushing with a standardized cycle that sends suspended particles through internal channels and digitally records each cycle.

The product development matters because Nanosonics is building beyond its established ultrasound probe disinfection business. The CORIS System was included in the Australian Register of Therapeutic Goods in 2025 and received De Novo clearance from the U.S. Food and Drug Administration in the same year, according to Biotech Dispatch.

Revenue grows as profit contracts

The latest full-year figures show a more mixed operating picture. According to Simply Wall St, fiscal 2026 revenue rose 2.7 percent to AUD 203.9 million from fiscal 2025, while net income fell 14 percent to AUD 17.8 million. Earnings per share declined to AUD 0.059 from AUD 0.068, and profit margin decreased to 8.7 percent from 10 percent.

That gap between revenue growth and profit performance is the central financial question for investors. New products can widen Nanosonics' addressable market, but the fiscal 2026 figures show that sales expansion did not translate into higher net income.

Analyst target remains above price

Consensus data published by Simply Wall St on September 25, 2026, put the average target from 7 analysts at AUD 3.88, down from AUD 4.23. The target was AUD 1.01, or 35.2 percent, above the AUD 2.87 reference price.

Nanosonics stock traded within an AUD 2.640 to AUD 4.760 52-week range on the October 7 snapshot. The AUD 2.870 price was AUD 0.010 above the prior close of AUD 2.860, a daily gain of 0.35 percent.

Stock remains below yearly high

Nanosonics stock was last at AUD 2.870 on the ASX on October 7, 2026, while the annual general meeting is scheduled for November 4, 2026.

Nanosonics stock facts

  • Company: Nanosonics Limited
  • ISIN: AU000000NAN9
  • Ticker: NAN
  • Trading venue: ASX
  • Price (as of October 7, 2026, 11:18 a.m. AEDT): AUD 2.870
  • 52-week range: AUD 2.640-4.760
  • Market capitalization: AUD 860.9 million (as of October 3, 2026)
  • Sector / Industry: Health Care / Medical Equipment and Supplies

Upcoming dates for Nanosonics stock

  • November 4, 2026: Annual general meeting

More news and analysis on Nanosonics stock

Disclaimer...

en | AU000000NAN9 | NANOSONICS | boerse | 70262742 | bgmi